Sedic M - Search Results

1

Functional genomics in identification of drug targets in Dupuytren's contracture.

Sedic M, Jurisic D, Stanec Z, Hock K, Pavelic K, Kraljevic Pavelic S. Sedic M, et al. Front Biosci (Landmark Ed). 2010 Jan 1;15(1):57-64. doi: 10.2741/3606. Front Biosci (Landmark Ed). 2010. PMID: 20036806 Free article. Review.

2

Global approach to perinatal medicine: functional genomics and proteomics.

Kralj M, Kraljević S, Sedić M, Kurjak A, Pavelić K. Kralj M, et al. Among authors: sedic m. J Perinat Med. 2005;33(1):5-16. doi: 10.1515/JPM.2005.001. J Perinat Med. 2005. PMID: 15841607 Review.

3

Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view?

Kraljevic S, Sedic M, Scott M, Gehrig P, Schlapbach R, Pavelic K. Kraljevic S, et al. Among authors: sedic m. Cancer Treat Rev. 2006 Dec;32(8):619-29. doi: 10.1016/j.ctrv.2006.09.002. Epub 2006 Oct 25. Cancer Treat Rev. 2006. PMID: 17069979 Review.

4

Novel cyano- and amidino-substituted derivatives of styryl-2-benzimidazoles and benzimidazo[1,2-a]quinolines. Synthesis, photochemical synthesis, DNA binding, and antitumor evaluation, part 3.

Hranjec M, Kralj M, Piantanida I, Sedić M, Suman L, Pavelić K, Karminski-Zamola G. Hranjec M, et al. Among authors: sedic m. J Med Chem. 2007 Nov 15;50(23):5696-711. doi: 10.1021/jm070876h. Epub 2007 Oct 13. J Med Chem. 2007. PMID: 17935309

5

Differential antiproliferative mechanisms of novel derivative of benzimidazo[1,2-alpha]quinoline in colon cancer cells depending on their p53 status.

Sedic M, Poznic M, Gehrig P, Scott M, Schlapbach R, Hranjec M, Karminski-Zamola G, Pavelic K, Kraljevic Pavelic S. Sedic M, et al. Mol Cancer Ther. 2008 Jul;7(7):2121-32. doi: 10.1158/1535-7163.MCT-07-2261. Mol Cancer Ther. 2008. PMID: 18645022

6

An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease.

Kraljevic Pavelic S, Sedic M, Hock K, Vucinic S, Jurisic D, Gehrig P, Scott M, Schlapbach R, Cacev T, Kapitanovic S, Pavelic K. Kraljevic Pavelic S, et al. Among authors: sedic m. J Pathol. 2009 Mar;217(4):524-33. doi: 10.1002/path.2483. J Pathol. 2009. PMID: 19089850

7

Recombinant human granulocyte colony stimulating factor pre-screening and screening of stabilizing carbohydrates and polyols.

Pavisić R, Hock K, Mijić I, Horvatić A, Gecan M, Sedić M, Krajacić MB, Cindrić M. Pavisić R, et al. Among authors: sedic m. Int J Pharm. 2010 Mar 15;387(1-2):110-9. doi: 10.1016/j.ijpharm.2009.12.015. Epub 2009 Dec 18. Int J Pharm. 2010. PMID: 20005931

8

The unsaturated acyclic nucleoside analogues bearing a sterically constrained (Z)-4'-benzamido-2'-butenyl moiety: Synthesis, X-ray crystal structure study, cytostatic and antiviral activity evaluations.

Benci K, Wittine K, Radan M, Cetina M, Sedić M, Kraljević Pavelić S, Pavelić K, Clercq ED, Mintas M. Benci K, et al. Among authors: sedic m. Bioorg Med Chem. 2010 Sep 1;18(17):6249-57. doi: 10.1016/j.bmc.2010.07.035. Epub 2010 Aug 7. Bioorg Med Chem. 2010. PMID: 20696582

9

Evaluation of in vitro biological activity of O-alkylated hydroxamic derivatives of some nonsteroidal anti-inflammatory drugs.

Pavelić SK, Sedić M, Poznić M, Rajić Z, Zorc B, Pavelić K, Balzarini J, Mintas M. Pavelić SK, et al. Among authors: sedic m. Anticancer Res. 2010 Oct;30(10):3987-94. Anticancer Res. 2010. PMID: 21036712

10

Metastasis: new perspectives on an old problem.

Kraljevic Pavelic S, Sedic M, Bosnjak H, Spaventi S, Pavelic K. Kraljevic Pavelic S, et al. Among authors: sedic m. Mol Cancer. 2011 Feb 22;10:22. doi: 10.1186/1476-4598-10-22. Mol Cancer. 2011. PMID: 21342498 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters